Anti-NMDAR encephalitis. How and when to suspect it?

Authors

  • Natasha Smiliansky Servicio de Medicina Interna, Clínica Médica 3, Hospital Maciel. Universidad de la República (UdelaR), Montevideo, Uruguay https://orcid.org/0000-0002-8254-5682
  • María Victoria Iraola Cátedra de Neumonología, Hospital Maciel, Universidad de la República (UdelaR), Montevideo, Uruguay
  • Carolina Díaz-Cuña Servicio de Medicina Interna, Clínica Médica 3, Hospital Maciel. Universidad de la República (UdelaR), Montevideo, Uruguay
  • Gustavo Bruno Servicio de Medicina Interna, Clínica Médica 3, Hospital Maciel. Universidad de la República (UdelaR), Montevideo, Uruguay

DOI:

https://doi.org/10.32818/reccmi.a6n1a5

Keywords:

encephalitis, autoinmune, anti-NMDAR.

Abstract

The prevalence of autoimmune encephalitis is uncertain, it mainly affects young people and children and the clinical presentation is variable. Autoimmune encephalitis is commonly confused with psychiatric pathologies, for this reason a high clinical suspicion must be had. The prognosis of these patients depends on the early start of treatment. We presents the clinical case of female, 21 years old, who presents 1 month evolution of altered behavior and hallucinations, in evolution develops headache and fever, and finally, she is diagnosed anti-NMDA encephalitis.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA et al. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol. 2018; 83(1): 166-177. doi: https://doi.org/10.1002/ana.25131.

Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis. 2012; 54(7): 899-904. doi: https://doi.org/10.1093/cid/cir1038.

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016; 15(4): 391-404. doi: https://doi.org/10.1016/S1474-4422(15)00401-9.

Dalmau J, Graus F. Antibody-Mediated Encephalitis. N Engl J Med. 2018; 378(9): 840-851. doi: https://doi.org/10.1056/NEJMra1708712.

Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008; 7(12): 1091-8. doi: https://doi.org/10.1016/S1474-4422(08)70224-2.

Lancaster E. The Diagnosis and Treatment of Autoimmune Encephalitis. J Clin Neurol. 2016; 12(1): 1-13. doi: https://doi.org/10.3988/jcn.2016.12.1.1.

Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013; 12(2): 157-65. doi: https://doi.org/10.1016/S1474-4422(12)70310-1.

Dutra LA, Abrantes F, Toso FF, Pedroso JL, Barsottini OGP, Hoftberger R. Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr. 2018; 76(1): 41-49. doi: https://doi.org/10.1590/0004-282X20170176.

Published

2021-04-30

How to Cite

1.
Smiliansky N, Iraola MV, Díaz-Cuña C, Bruno G. Anti-NMDAR encephalitis. How and when to suspect it?. Rev Esp Casos Clin Med Intern [Internet]. 2021 Apr. 30 [cited 2024 Dec. 22];6(1):13-5. Available from: https://www.reccmi.com/RECCMI/article/view/589